Slc25a39 and slc25a40 expression in mice with bile duct ligation or lipopolysaccharide treatment

HIGHLIGHTS

  • who: Atsushi Kawase and collaborators from the Department of Pharmacy, Faculty of Pharmacy, Kindai University, Kowakae, Higashiosaka, Osaka, Japan have published the research work: Slc25a39 and Slc25a40 Expression in Mice with Bile Duct Ligation or Lipopolysaccharide Treatment, in the Journal: (JOURNAL)
  • what: Mice with BDL exhibited a decrease in Slc25a39/40 expression in the kidneys, associated with a reduction in mGSH levels.
  • how: The authors conducted an in_vitro study using human clear cell renal carcinoma (KMRC-1) cells to clarify the mechanism of regulation of SLC25A39/40 expression in the kidneys following LPS . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?